| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/03/2007 | US7199098 Copolymer-1 improvements in compositions of copolymers |
| 04/03/2007 | US7199097 Peptide fragments having cell death inhibitory activity |
| 04/03/2007 | US7198950 Self-inactivating plasmid/vector; gene therapy; treating hematological disorders; anticarcinogenic agents |
| 04/03/2007 | US7198949 Compositions and methods for altering the biodistribution of biological agents |
| 04/03/2007 | US7198948 Methods and compositions for obtaining mature dendritic cells |
| 04/03/2007 | US7198947 isolating mammalian cells; placing said cells into a rotating wall vessel containing a cell culture comprising culture media and culture matrix; producing three-dimensional cell aggregates under simulated microgravity conditions; and detecting expression of 1- alpha -hydroxylase expression |
| 04/03/2007 | US7198944 for the treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, wound healing and psoriasis |
| 04/03/2007 | US7198931 Comprises mamamlian glyoxylase for modulating advanced glycation end products (AGEs) and diagnosis and treatment of vision defects and diabetes |
| 04/03/2007 | US7198929 Nucleotide sequences coding eukaryotic initiation factor-2 kinase for use in the identification of modulators which prevent and treat viral and liver disorders |
| 04/03/2007 | US7198920 HER-2/neu fusion proteins |
| 04/03/2007 | US7198918 Recombinant DNA formed by ligating; gene expression; suppressing proliferation; medicine/drugs; host cell |
| 04/03/2007 | US7198917 Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens |
| 04/03/2007 | US7198913 Nucleotide sequences coding polypeptide for use in the treatment of apoptosis, inflammatory and autoimmune disorders |
| 04/03/2007 | US7198912 Polynucleotides encoding a human G-protein coupled receptor, HGPRBMY39 |
| 04/03/2007 | US7198911 Identification and cloning of a novel human gene, RET16, involved in the intracellular signaling cascade |
| 04/03/2007 | US7198910 Nucleic acid encoding melanin-concentrating hormone receptor |
| 04/03/2007 | US7198892 Hepatitis-C virus type 4, 5 and 6 |
| 04/03/2007 | US7198798 Providing to one or more endothelial cells an amount of an osteoprotegerin sufficient to promote endothelial morphogenesis |
| 04/03/2007 | US7198796 Antifungal parenteral products |
| 04/03/2007 | US7198791 Immunostimulants comprising epitopes from a malarial blood-stage protein |
| 04/03/2007 | US7198790 Growth differentiation factor-5 |
| 04/03/2007 | US7198789 Methods and compositions for modulating interleukin-21 receptor activity |
| 04/03/2007 | US7198788 Administering pharmaceutical formulation comprising an anti-CD26 antibody, whereby the anti- CD26 antibody binds CD26 and arrests cell cycle for therapy of cancer |
| 04/03/2007 | US7198786 Administering to the wound surface a fibrinogen solution in an amount of 0.025 - 0.25 ml fibrinogen/cm2 |
| 04/03/2007 | US7198785 Systems and methods related to degradation of uremic toxins |
| 04/03/2007 | US7198782 Using receptor binding peptide to treat and prevent pancreatic disorders; peptide mimetics; antidiabetic agents |
| 04/03/2007 | US7198781 Chimeric interleukin-6 soluble receptor/ligand proteins |
| 04/03/2007 | CA2276459C Novel method for testing the differentiation status in pancreatic cells of a mammal |
| 04/03/2007 | CA2238295C Complementary adenoviral vector systems and cell lines |
| 04/03/2007 | CA2236679C Differentiation-suppressive polypeptide |
| 04/03/2007 | CA2192822C Use of immunosuppressive agents for the treatment of schizophrenia |
| 04/03/2007 | CA2183430C Biologic bioadhesive compositions containing fibrin glue and liposomes, methods of preparation and use |
| 04/03/2007 | CA2176943C Mutants of bone morphogenetic proteins |
| 04/03/2007 | CA2162397C Ligands for flt3 receptors |
| 04/03/2007 | CA2157530C Somatostatin analogs containing chelating groups and their radiolabeled compositions |
| 04/03/2007 | CA2108770C Bmp-9 compositions |
| 04/03/2007 | CA2107914C Method to profile and treat abnormal cells |
| 04/03/2007 | CA2103195C Method for the production of proteins in plant fluids |
| 04/03/2007 | CA2089661C Transgenic non-human animals capable of producing heterologous antibodies |
| 03/29/2007 | WO2007035828A2 Compositions and methods for preventing or treating encephalitis with interferon |
| 03/29/2007 | WO2007035782A2 Protein kinase c peptide modulators of angiogenesis |
| 03/29/2007 | WO2007035759A1 Modulation of glucocorticoid receptor expression |
| 03/29/2007 | WO2007035757A2 Composition and method for treating iron deficiency anemia |
| 03/29/2007 | WO2007035678A2 Methods of identifying agents having antiangiogenic activity |
| 03/29/2007 | WO2007035583A1 Lyophilization of hemoglobin solutions |
| 03/29/2007 | WO2007035474A2 Transdermal delivery peptides and method of use thereof |
| 03/29/2007 | WO2007035191A1 Use of interferon tau for treating il-10 deficiency |
| 03/29/2007 | WO2007035180A1 Method of treating pulmonary disease with interferons |
| 03/29/2007 | WO2007034807A1 Dipeptide-containing composition for oral administration |
| 03/29/2007 | WO2007034753A1 Remedy for angiogenesis-related disease comprising chondromodulin-i as the active ingredient |
| 03/29/2007 | WO2007034678A1 Novel antifungal agent |
| 03/29/2007 | WO2007034509A2 Recombinant granulocyte-colony stimulating factor formulation and process |
| 03/29/2007 | WO2007034498A1 Atrial natriuretic peptide (anp) splice variants and methods of using same |
| 03/29/2007 | WO2007034262A1 Heterodimeric meganucleases and use thereof |
| 03/29/2007 | WO2007033529A1 A gene encoding antibacterial protein of fenneropenaeus chinensis and its recombination expression method and uses |
| 03/29/2007 | WO2007033444A2 Antiviral therapy with carbohydrate binding agents |
| 03/29/2007 | WO2007033427A1 Stabilisation of peptides with basic amino acids |
| 03/29/2007 | WO2007013807A3 Targeting-enhanced activation of galectins |
| 03/29/2007 | WO2007009946A3 Process for the manufacture of eptifibatide |
| 03/29/2007 | WO2006135925A3 Methods to reduce oxalate concentration by administration of oxalate oxidase crystals |
| 03/29/2007 | WO2006128911A3 Use of il-18bp isoforms for the treatment and/or prevention of neurological inflammatory diseases |
| 03/29/2007 | WO2006128084A3 Trps1-mediated modulation of hair growth |
| 03/29/2007 | WO2006122178A3 A method for modulating hla class ii tumor cell surface expression with a cytokine mixture |
| 03/29/2007 | WO2006118719A3 Method of improving learning and memory in mammals |
| 03/29/2007 | WO2006116185A3 Methods for the treatment of multiple myeloma |
| 03/29/2007 | WO2006111745A3 Composition and method for treating viral infection |
| 03/29/2007 | WO2006108128A3 Ocular delivery of interferon-tau |
| 03/29/2007 | WO2006099170A3 Beta-polypeptides that inhibit cytomegalovirus infection |
| 03/29/2007 | WO2006086454A3 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
| 03/29/2007 | WO2006074341A3 Novel use |
| 03/29/2007 | WO2006073771A3 Polyethylene glycol linked mc4r or mc3r agonist peptides |
| 03/29/2007 | WO2006072625A8 Anti-kir combination treatments and methods |
| 03/29/2007 | WO2006071603A9 Phosphodiesterase 4d in the ryanodine receptor complex protects against heart failure |
| 03/29/2007 | WO2006055635A3 Compositions and methods for altering wnt autocrine signaling |
| 03/29/2007 | WO2006053015A3 Composition and method for increasing apoptosis in cancer cells |
| 03/29/2007 | WO2006047380A3 Method and media for single cell serum-fee culture of cho cells |
| 03/29/2007 | WO2006021814A3 Medicament |
| 03/29/2007 | WO2006013336A9 Hpv vaccine comprising peptides from host cell proteins |
| 03/29/2007 | WO2006009682A3 Glue compositions for lung volume reduction |
| 03/29/2007 | WO2005120558A3 Methods for making compositions comprising heat shock proteins or alpha-2-macroglobulin for the treatment of cancer and infectious disease |
| 03/29/2007 | WO2005074524A3 Modified human interferon polypeptides and their uses |
| 03/29/2007 | WO2002056916A8 Compositions and methods for enhanced pharmacological activity through oral and parenteral administration of compositions comprising polypeptide drug substances and other poorly absorbed active ingredients |
| 03/29/2007 | US20070074296 RTD receptor |
| 03/29/2007 | US20070074295 Schizophrenia related gene |
| 03/29/2007 | US20070073047 Genes overexpressed by ovarian cancer and their use in developing novel therapeutics |
| 03/29/2007 | US20070073044 Homogeneous preparations of il-28 and il-29 |
| 03/29/2007 | US20070073043 Process for producing humanized chimera antibody |
| 03/29/2007 | US20070073042 Novel MHC II associated peptides |
| 03/29/2007 | US20070073040 Anti-obesity polypeptides |
| 03/29/2007 | US20070073039 Peptides that inhibit viral infections |
| 03/29/2007 | US20070072935 Catalytic antioxidants and methods of use |
| 03/29/2007 | US20070072872 Treating sexual desire disorders with flibanserin |
| 03/29/2007 | US20070072841 Therapeutic compounds |
| 03/29/2007 | US20070072822 STAT3 agonists and antagonists and therapeutic uses thereof |
| 03/29/2007 | US20070072820 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 03/29/2007 | US20070072819 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 03/29/2007 | US20070072818 Endothelial growth factors; antiischemic agents; neovascularization |
| 03/29/2007 | US20070072817 Methods for reducing blood pressure |
| 03/29/2007 | US20070072816 Methods for inhibiting angiogenesis |
| 03/29/2007 | US20070072810 Agent for treating diabetes |